Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Read More…
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Phone978-663-3660
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.90 billion
Profitability
Miscellaneous
Employees6,870
Next Earnings Date2/10/2020 (Estimated)
OptionableOptionable
Bruker (NASDAQ:BRKR) Frequently Asked Questions
What is Bruker's stock symbol?
Bruker trades on the NASDAQ under the ticker symbol "BRKR."
How often does Bruker pay dividends? What is the dividend yield for Bruker?
Bruker declared a quarterly dividend on Thursday, November 14th. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.04 per share on Friday, December 20th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Friday, November 29th. View Bruker's Dividend History.
How were Bruker's earnings last quarter?
Bruker Co. (NASDAQ:BRKR) posted its quarterly earnings results on Thursday, October, 31st. The medical research company reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.05. The medical research company earned $521.10 million during the quarter, compared to the consensus estimate of $493.52 million. Bruker had a return on equity of 28.02% and a net margin of 10.20%. Bruker's revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.37 EPS. View Bruker's Earnings History.
When is Bruker's next earnings date?
What price target have analysts set for BRKR?
13 Wall Street analysts have issued 1-year target prices for Bruker's stock. Their forecasts range from $39.00 to $60.00. On average, they anticipate Bruker's share price to reach $50.58 in the next twelve months. This suggests that the stock has a possible downside of 3.5%. View Analyst Price Targets for Bruker.
What is the consensus analysts' recommendation for Bruker?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 4 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.
Has Bruker been receiving favorable news coverage?
Media headlines about BRKR stock have been trending extremely negative this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bruker earned a coverage optimism score of -4.5 on InfoTrie's scale. They also gave news articles about the medical research company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Bruker.
Who are some of Bruker's key competitors?
Some companies that are related to Bruker include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).
What other stocks do shareholders of Bruker own?
Who are Bruker's key executives?
Bruker's management team includes the folowing people:
- Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
- Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
- Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
- Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
- Dr. Falko Busse, Exec. Officer (Age 52)
Who are Bruker's major shareholders?
Bruker's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (0.33%), Scout Investments Inc. (0.16%), Mckinley Capital Management LLC Delaware (0.06%), Sheets Smith Wealth Management (0.01%), Strs Ohio (0.01%) and Calamos Advisors LLC (0.01%). Company insiders that own Bruker stock include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Institutional Ownership Trends for Bruker.
Which institutional investors are selling Bruker stock?
BRKR stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., Nisa Investment Advisors LLC, Campbell & CO Investment Adviser LLC and NEXT Financial Group Inc. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Insider Buying and Selling for Bruker.
Which institutional investors are buying Bruker stock?
BRKR stock was bought by a variety of institutional investors in the last quarter, including Mckinley Capital Management LLC Delaware, Sheets Smith Wealth Management, Boston Trust Walden Corp, Strs Ohio, Lipe & Dalton, Zurcher Kantonalbank Zurich Cantonalbank , Huntington National Bank and Calamos Advisors LLC. View Insider Buying and Selling for Bruker.
How do I buy shares of Bruker?
Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Bruker's stock price today?
One share of BRKR stock can currently be purchased for approximately $52.40.
How big of a company is Bruker?
Bruker has a market capitalization of $8.07 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.View Additional Information About Bruker.
What is Bruker's official website?
How can I contact Bruker?
Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]
MarketBeat Community Rating for Bruker (NASDAQ BRKR)
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
